Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study

Blood (2021) 137 (13): 1818–1827.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals